Results 171 to 180 of about 2,338 (236)

Microfluidic technologies for wearable and implantable biomedical devices.

Lab Chip
Wang Z, Shah A, Lee H, Lee CH.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A complication of the implantable constant infusion chemotherapy pump

Journal of Surgical Oncology, 1984
AbstractThe treatment of metastatic colorectal cancer to the liver has been a significant problem for clinicians in the past. Recent technical advances in infusion systems in the form of the infusaid pump has allowed delivery of chemotherapeutic agents to the liver with great reliability.
Joseph J Pietrafitta
exaly   +3 more sources

Implanted Hepatic Arterial Infusion Pumps

The Cancer Journal, 2010
Globally, the number of colorectal carcinoma-related deaths totals close to 600,000 each year, with metastatic disease representing the major cause of morbidity and mortality. The liver is the most common site of metastasis for patients diagnosed with colorectal carcinoma.
Margaret K, Callahan, Nancy E, Kemeny
openaire   +2 more sources

Development of an Implantable Intrathecal Drug Infusion Pump

The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, 2005
An intrathecal drug infusion system has been designed, manufactured and tested. The system is composed of a drug reservoir and a pump/controller assembly. The drug reservoir made of SUS316L is a negative pressure gas chamber enclosing a bellows type drug chamber.
S, Hong, J S, Lee, J W, Park, K, Nam, J, Choi, J C, Lee, J K, Park, Y P, Ko, Y H, Jo   +8 more
openaire   +2 more sources

Complications Associated with Infusion Pumps Implanted for Spasticity

Stereotactic and Functional Neurosurgery, 1996
Implanted infusion pumps are an effective method for delivering medications into the intrathecal space to reduce spasticity. Complications can occur with the surgical aspect of implantation, as well as with the hardware. We describe an 8-year experience with the implantation of 34 infusion pumps in 30 patients in whom either morphine or baclofen was ...
A B, Levin, K B, Sperling
openaire   +2 more sources

External and Implanted Pumps for Apomorphine Infusion in Parkinsonism

1993
Continuous delivery of dopaminergic agents to the striatum is a major challenge to improve the treatment of Parkinson's disease. Apomorphine is one of the best candidates because of its solubility and its D1 and D2 receptor agonist properties. Seventeen Parkinsonian patients suffering from severe L-dopa-induced on-off effects were treated by continuous
P, Pollak, A L, Benabid, P, Limousin, C L, Gervason, E, Jeanneau-Nicolle   +4 more
openaire   +2 more sources

MR imaging of patients with implanted drug infusion pumps

Journal of Magnetic Resonance Imaging, 1991
AbstractThe influence of magnetic resonance (MR) imaging on the integrity and function of an implantable, programmable drug infusion pump and the distortion of the image by this device were tested. Six identical pumps were tested in magnetic fields of 1.5 T. Pump memory was not affected by the procedure.
R, von Roemeling, R M, Lanning, F A, Eames   +2 more
openaire   +2 more sources

Continuous infusion with implantable pumps: expanding the radiologist's role

European Journal of Radiology, 1991
Drug infusion systems attract increasing attention as biomedical technology offers miniaturized devices for targeted delivery of therapeutic substances on an outpatient basis. We have used a totally implantable, subcutaneous pump, externally programmable by radiofrequency link, learning the technique of implantation and management and using various ...
B, Damascelli, M G, Bonalumi, A, Marchianò, C, Spreafico, F, Garbagnati, A, Amadeo, M, Salvetti, L F, Frigerio, G, Piragine, A, Cesa Bianchi   +9 more
openaire   +2 more sources